Woodstock Corp Cuts Position in UnitedHealth Group Incorporated (NYSE:UNH)

Woodstock Corp trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 6.5% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 834 shares of the healthcare conglomerate’s stock after selling 58 shares during the quarter. Woodstock Corp’s holdings in UnitedHealth Group were worth $428,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Advocacy Wealth Management Services LLC grew its stake in UnitedHealth Group by 75.8% during the 1st quarter. Advocacy Wealth Management Services LLC now owns 58 shares of the healthcare conglomerate’s stock worth $30,000 after buying an additional 25 shares during the last quarter. Cascade Investment Advisors Inc. grew its stake in UnitedHealth Group by 100.0% during the 1st quarter. Cascade Investment Advisors Inc. now owns 60 shares of the healthcare conglomerate’s stock worth $31,000 after buying an additional 30 shares during the last quarter. Evolution Advisers Inc. acquired a new stake in UnitedHealth Group during the 1st quarter worth about $38,000. Rise Advisors LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth about $38,000. Finally, Cordant Inc. acquired a new stake in UnitedHealth Group during the 1st quarter worth about $45,000. 87.25% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Price Performance

UNH stock opened at $521.02 on Monday. The company has a debt-to-equity ratio of 0.60, a current ratio of 0.77 and a quick ratio of 0.77. The business has a 50 day simple moving average of $529.29 and a 200-day simple moving average of $511.81. The firm has a market capitalization of $487.35 billion, a PE ratio of 27.21, a price-to-earnings-growth ratio of 1.63 and a beta of 0.76. UnitedHealth Group Incorporated has a 1 year low of $383.12 and a 1 year high of $553.29.

UnitedHealth Group (NYSE:UNHGet Rating) last posted its quarterly earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.24 by $0.33. The business had revenue of $80.33 billion during the quarter, compared to analyst estimates of $79.68 billion. UnitedHealth Group had a return on equity of 25.45% and a net margin of 5.95%. The business’s revenue was up 12.6% compared to the same quarter last year. During the same period in the prior year, the business earned $4.70 earnings per share. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 21.85 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 20th. Investors of record on Monday, September 12th will be given a $1.65 dividend. The ex-dividend date is Friday, September 9th. This represents a $6.60 annualized dividend and a yield of 1.27%. UnitedHealth Group’s payout ratio is 34.46%.

Insider Buying and Selling

In related news, CAO Thomas E. Roos sold 465 shares of the stock in a transaction that occurred on Friday, August 26th. The stock was sold at an average price of $542.37, for a total value of $252,202.05. Following the completion of the transaction, the chief accounting officer now directly owns 34,786 shares in the company, valued at $18,866,882.82. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In other UnitedHealth Group news, CEO Andrew Witty sold 11,376 shares of the company’s stock in a transaction on Monday, July 18th. The stock was sold at an average price of $527.90, for a total transaction of $6,005,390.40. Following the transaction, the chief executive officer now directly owns 76,559 shares in the company, valued at $40,415,496.10. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Thomas E. Roos sold 465 shares of the company’s stock in a transaction on Friday, August 26th. The stock was sold at an average price of $542.37, for a total value of $252,202.05. Following the transaction, the chief accounting officer now owns 34,786 shares in the company, valued at $18,866,882.82. The disclosure for this sale can be found here. Over the last three months, insiders sold 140,324 shares of company stock worth $75,086,185. Company insiders own 0.40% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have commented on UNH. UBS Group lifted their price target on UnitedHealth Group from $545.00 to $570.00 and gave the stock a “neutral” rating in a research report on Thursday, July 21st. Loop Capital initiated coverage on UnitedHealth Group in a research report on Thursday, June 16th. They set a “buy” rating and a $575.00 price target for the company. Argus boosted their price objective on UnitedHealth Group from $580.00 to $650.00 and gave the company a “buy” rating in a report on Monday, July 25th. BMO Capital Markets boosted their price objective on UnitedHealth Group from $600.00 to $610.00 in a report on Wednesday, July 20th. Finally, Mizuho boosted their price objective on UnitedHealth Group from $550.00 to $600.00 and gave the company a “buy” rating in a report on Wednesday, August 10th. Three research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and an average target price of $585.65.

UnitedHealth Group Company Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Recommended Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.